drugset / Trial / NCT00223249

Quetiapine in Patients With Bipolar and Alcohol Abuse/Dependence

NCT00223249

Phase 4 Completed 115 enrolled University of Texas Southwestern Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The abuse of alcohol is especially common in people with bipolar disorder. However, very little is known about the pharmacotherapy of people with both bipolar disorder and alcohol abuse/dependence. The purpose of this study is to determine if alcohol use and cravings are decreased with quetiapine add-on therapy compared to placebo and to determine if quetiapine add-on therapy is associated with greater improvement in mood, impulsivity, functioning and decreased alcohol use than placebo.

Timeline

Start
2002-11
Primary completion
2004-08
Completion
2004-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Quetiapine Small molecule 600 mg